Posts by Sandra Ansanay-Alex
BioArk & New Mexico Venture Studios Partner to Boost Life Sciences Projects
BioArk & New Mexico Venture Studios have established a strategic partnership to support startups in life sciences, medtech, and deep tech. This alliance facilitates access to infrastructure, expertise, and markets between US and European markets, accelerating international growth and collaboration. Facilitating startup expansion and collaboration The partnership provides startup exchange programs, shared lab and…
Read MoreBioLNP Innovation and OneCell Protein, recipients of the EPFL Startup Launchpad Ignition Grant
Two EPFL-based startups: BioLNP Innovation and OneCell Protein, have become the latest recipients of the EPFL Startup Launchpad Ignition grant. The startups were each awarded a CHF30,000 grant to continue developing their technology. BioLNP Innovation Viruses (including Respiratory Syncytial Virus or Hepatitis B) are a major public health concern. While scientists have developed treatments…
Read MoreARCHIMED acquires cell line development pioneer ExcellGene
Global private equity healthcare specialist ARCHIMED acquires a majority stake in family-owned ExcellGene and sister company Magellan Biologics & Consulting (both in the biologic therapeutics sector), partnering with founders and management, to create a group covering gene transfer, cell line development and cell culture-based manufacturing for high-performance production of recombinant proteins, and other advanced therapeutics. Monthey, Switzerland-based ExcellGene, was created…
Read MoreBioscibex Receives CHF 150,000 from Venture Kick
EPFL spin-off Bioscibex, a biotechnology start-up specialising in bioproduction equipment, has secured CHF 150,000 in funding from Venture Kick. This fundraising will accelerate the market launch of Swingo, its first single-use bioreactor, designed to simplify and automate cell culture and thus make biological therapies more accessible. Biologics have transformed the treatment of cancer, autoimmune…
Read MoreMultiwave Technologies Secures CHF 3.6M and Expand Operations in the US
Geneva-based Multiwave Technologies AG has raised CHF 3.6 million (USD 4.5 million) in fresh funding to accelerate the development and regulatory approval of its portable MRI device, MGNTQ™, and to expand its global operations with a new assembly plant in Lowell, Massachusetts. The investment, completed across 2024 and 2025, comes from a group of…
Read MoreAdaptyv Raises CHF 6,40 million to Accelerate AI-Driven Protein Validation
Vaud-based startup Adaptyv, specializing in the experimental validation of AI-generated proteins, has raised CHF 6,40 million in seed funding. The round was led by Ace Ventures with participation from ByFounders, Founderful, LongGame, and several individual investors. At the same time, the company announced the public launch of its fully automated cloud laboratory platform, now…
Read MoreA Blood Test Designed to Differentiate Depression and Bipolar Disorder
ALCEDIAG, OM Pharma Suisse, and Unilabs announce the launch of EDIT-B®, the world’s first CE-marked and Swissmedic compliant blood test designed to differentiate depression and bipolar disorder, now available nationwide in clinical routine in Switzerland and Liechtenstein. This innovative diagnostic solution, a breakthrough in mental health diagnostics, will be accessible to clinicians and patients, addressing…
Read MoreCria Technologies secures CHF 40,000 at the second stage of Venture Kick
The Geneva-based and FONGIT incubated startup revolutionizes biopharma cold chain logistics Cria Technologies, is tackling one of the most pressing inefficiencies in the pharmaceutical and biotech cold chain: outdated, bulky, and fragile packaging systems that rely heavily on dry ice. These legacy solutions are increasingly inadequate for transporting emerging personalized therapies that require ultra-low…
Read MoredEEGtal Gets a CHF 640,000 Support From Innosuisse
dEEGtal Insight SA is a pioneering spin-off, of the Geneva University Hospitals (the EEG and Epilepsy Unit) and the University of Geneva, focused on transforming early detection and diagnosis of epilepsy. Innosuisse recently approved a CHF 640,000 support. This forward-thinking initiative leverages advanced AI-powered software to deliver precise and timely insights to neurologists, enabling…
Read MoreLichtsteiner Foundation
Try to be one of the 10 early-stage healthcare startups supported by the Lichtsteiner Foundation each year. Application accepted throughout the year. The purpose of the Lichtsteiner Foundation is to promote innovations in healthcare in order to improve people’s health worldwide. The Lichtsteiner Foundation is a charitable, tax-exempt, independent foundation under Swiss law with…
Read More